Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Optimal Intensity of Anticoagulation

By Yasaka M.   Yamaguchi T.  

CNS Drugs, Vol. 15, Iss. 8, 2001-01 ,pp. : 623-631

Adis International

Access to resources Recommend Favorite

Outcomes of Long-Term Anticoagulation in Frail Elderly Patients with Atrial Fibrillation

By Goldenberg G.M.   Silverstone F.A.   Rangu S.   Leventer S.L.  

Clinical Drug Investigation, Vol. 17, Iss. 6, 1999-06 ,pp. : 483-488

Adis International

Access to resources Recommend Favorite

Safety of the Combination of Intensive Cholesterol-Lowering Therapy with Oral Anticoagulation Medication in Elderly Patients with Atrial Fibrillation: A Randomized, Double-Blind, Placebo-Controlled Study

By Enajat Morteza  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 585-593

Adis International

Access to resources Recommend Favorite

What Should be the Primary Treatment in Atrial Fibrillation: Ventricular Rate Control or Sinus Rhythm Control with Long-term Anticoagulation?

By Okcun B   Yigit Z   Yildiz A   Uzunhasan I   Orta K   Baskurt M   Kaya A   Kucukoglu S  

The Journal of International Medical Research, Vol. 37, Iss. 2, 2009-03 ,pp. : 464-471

Field House Publishing

Access to resources Recommend Favorite

Anticoagulation prescription in atrial fibrillation

By Bertomeu-Gonzáález Vicente   Cordero Alberto   Mazóón Pilar   Moreno-Arribas Joséé   Fáácila Lorenzo   Nuññez Julio   Rodrííguez-Maññero Moiséés   Cosíín-Sales Juan   Gonzáález-Juanatey Jose Ramóón   Quiles Juan   Bertomeu-Martíínez Vicente  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1473-1479

Informa Healthcare

Access to resources Recommend Favorite